Patient Preferences for Disease Modifying Anti-Rheumatic Drug Treatment of Rheumatoid Arthritis: A Systematic Review

被引：0
|
作者：
Durand, Caylib [1 ]
Eldoma, Maysoon [1 ]
Marshall, Deborah [1 ]
Hazlewood, Glen [1 ]
机构：
[1] Univ Calgary, Calgary, AB, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2017年 / 44卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
78
引用
收藏
页码：889 / 889
页数：1
相关论文
共 50 条
  • [21] HOW REPRESENTATIVE OF THE RHEUMATOID ARTHRITIS (RA) PATIENT IS A GROUP ENTERED INTO A DISEASE MODIFYING ANTI-RHEUMATIC DRUG (DMARD) STUDY?
    Irvine, S.
    Hampson, R.
    Madhok, R.
    Capell, H. A.
    RHEUMATOLOGY, 2003, 42 : 96 - 97
  • [22] Cardiovascular outcomes of patients with rheumatoid arthritis prescribed disease modifying anti-rheumatic drugs: a review
    Giollo, Alessandro
    Bissell, Lesley-Anne
    Buch, Maya H.
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (07) : 697 - 708
  • [23] Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis
    Das, Priyam
    Weisenfeld, Dana
    Dahal, Kumar
    De, Debsurya
    Feathers, Vivi
    Coblyn, Jonathan S.
    Weinblatt, Michael E.
    Shadick, Nancy A.
    Cai, Tianxi
    Liao, Katherine P.
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [24] Effects of biologic disease-modifying anti-rheumatic drugs on the radiographic progression of rheumatoid arthritis: a systematic literature review
    Combe, Bernard
    Durez, Patrick
    Boone, Caroline
    Lula, Sadiq
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (04) : 658 - 667
  • [25] German guidelines for the treatment of rheumatoid arthritis with disease modifying anti-rheumatic drugs - What is new?
    Fiehn, Christoph
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2020, 145 (07) : 474 - 479
  • [26] THE IMPACT OF EDUCATION ON ADHERENCE TO TREATMENT WITH DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS PATIENTS
    Holc, I.
    Pahor, A.
    Gradisnik, S.
    Dai, K.
    Krajnc, M. Koren
    Grobelsek, V. Kovacic
    Dobnik, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 706 - 707
  • [27] The role of registries in the treatment of rheumatoid arthritis with biologic disease-modifying anti-rheumatic drugs
    Pombo-Suarez, Manuel
    Gomez-Reino, Juan
    PHARMACOLOGICAL RESEARCH, 2019, 148
  • [28] Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis
    Priyam Das
    Dana Weisenfeld
    Kumar Dahal
    Debsurya De
    Vivi Feathers
    Jonathan S. Coblyn
    Michael E. Weinblatt
    Nancy A. Shadick
    Tianxi Cai
    Katherine P. Liao
    Arthritis Research & Therapy, 25
  • [29] Time to Disease-Modifying Anti-Rheumatic Drug Treatment for New Patients with Rheumatoid Arthritis - Single Center Experience
    Jese, Rok
    Ambrozic, Ales
    Gaspersic, Natasa
    Hocevar, Alojzija
    Lestan, Boris
    Novljan, Martina Plesivcnik
    Praprotnik, Sonja
    Rotar, Ziga
    Dolnicar, Alenka Sipek
    Tomsic, Matija
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [30] Clinical utility of therapeutic drug monitoring in biological disease modifying anti-rheumatic drug treatment of rheumatic disorders: a systematic narrative review
    Van Herwaarden, Noortje
    Van den Bemt, Bart J. F.
    Wientjes, Maike H. M.
    Kramers, Cornelis
    Den Broeder, Alfons A.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2017, 13 (08) : 843 - 857
12345